International Business Machines Management
Management criteria checks 2/4
International Business Machines' CEO is Arvind Krishna, appointed in Apr 2020, has a tenure of 4.67 years. total yearly compensation is $20.40M, comprised of 7.4% salary and 92.6% bonuses, including company stock and options. directly owns 0.043% of the company’s shares, worth R$538.49M. The average tenure of the management team and the board of directors is 4.7 years and 10.1 years respectively.
Key information
Arvind Krishna
Chief executive officer
US$20.4m
Total compensation
| CEO salary percentage | 7.4% |
| CEO tenure | 4.7yrs |
| CEO ownership | 0.04% |
| Management average tenure | 4.7yrs |
| Board average tenure | 10.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$6b |
| Jun 30 2024 | n/a | n/a | US$8b |
| Mar 31 2024 | n/a | n/a | US$8b |
| Dec 31 2023 | US$20m | US$2m | US$8b |
| Sep 30 2023 | n/a | n/a | US$7b |
| Jun 30 2023 | n/a | n/a | US$2b |
| Mar 31 2023 | n/a | n/a | US$2b |
| Dec 31 2022 | US$17m | US$2m | US$2b |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$6b |
| Mar 31 2022 | n/a | n/a | US$5b |
| Dec 31 2021 | US$18m | US$2m | US$5b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$3b |
| Mar 31 2021 | n/a | n/a | US$3b |
| Dec 31 2020 | US$17m | US$1m | US$4b |
Compensation vs Market: Arvind's total compensation ($USD20.40M) is above average for companies of similar size in the BR market ($USD5.71M).
Compensation vs Earnings: Arvind's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Arvind Krishna (61 yo)
4.7yrs
Tenure
US$20,398,426
Compensation
Mr. Arvind Krishna serves as an Independent Director of Northrop Grumman Corporation since November 2022. He serves as Director at Federal Reserve Bank of New York since 2022. He serves as Chairman of the...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 4.7yrs | US$20.40m | 0.043% R$ 538.5m | |
| Executive Vice Chairman | 3.9yrs | US$9.54m | 0.0071% R$ 89.2m | |
| Senior VP & CFO | 6.9yrs | US$11.69m | 0.013% R$ 168.8m | |
| Senior VP of Software & Chief Commercial Officer | 4.9yrs | US$10.33m | 0.0068% R$ 85.6m | |
| Senior Vice President of Transformation & Operations | 1.3yrs | no data | no data | |
| Senior VP of Strategy | no data | no data | no data | |
| Senior VP & Chief Legal Officer | less than a year | no data | no data | |
| Senior Vice President of Marketing & Communications | 4.9yrs | no data | no data | |
| Senior VP & Chief Human Resources Officer | 4.3yrs | no data | 0.0027% R$ 34.6m | |
| Chief Innovation Officer Emeritus | 19.2yrs | no data | no data | |
| VP of Sales and Head of The Industry Solutions Area In Central & Eastern Europe | no data | no data | no data | |
| Senior VP & Director of IBM Research | no data | no data | no data |
4.7yrs
Average Tenure
57.5yo
Average Age
Experienced Management: IBMB34's management team is considered experienced (4.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 4.7yrs | US$20.40m | 0.043% R$ 538.5m | |
| Executive Vice Chairman | 3.9yrs | US$9.54m | 0.0071% R$ 89.2m | |
| Independent Director | 12.9yrs | US$469.33k | 0.00092% R$ 11.6m | |
| Independent Director | 9.9yrs | US$539.91k | no data | |
| Independent Director | 7.2yrs | US$487.06k | 0.00041% R$ 5.2m | |
| Independent Director | 14.8yrs | US$602.31k | 0.00029% R$ 3.6m | |
| Lead Independent Director | 10.3yrs | US$569.76k | 0.00048% R$ 6.0m | |
| Member of Watson Healthcare Advisory Board | 12.8yrs | no data | no data | |
| Member of Watson Healthcare Advisory Board | no data | no data | no data | |
| Member of Watson Healthcare Advisory Board | no data | no data | no data | |
| Member of Watson Healthcare Advisory Board | no data | no data | no data | |
| Member of Watson Healthcare Advisory Board | no data | no data | no data |
10.1yrs
Average Tenure
66yo
Average Age
Experienced Board: IBMB34's board of directors are seasoned and experienced ( 10.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 13:30 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
International Business Machines Corporation is covered by 73 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James Kelleher | Argus Research Company |
| Josep Bori | Atlantic Equities LLP |
| Ishan Majumdar | Baptista Research |